Combination Gene Therapy
Depletion of neutralizing antibodies to enable gene/enzyme therapies
Pre-clinicalActive
Key Facts
Indication
Depletion of neutralizing antibodies to enable gene/enzyme therapies
Phase
Pre-clinical
Status
Active
Company
About Hemotune
Hemotune is pioneering a magnetic nanoparticle separation platform with applications across healthcare and industrial bioprocessing. Its lead medical programs target enabling safer gene therapies by depleting neutralizing antibodies and treating sepsis through multi-target blood purification. The company operates as a private, platform-based biotech, leveraging its tunable HemoBead technology for both therapeutic and bioseparation partnerships.
View full company profile